Vainutis K. Vaitkevicius

Author

Wayne State University

Also Known As

V K Vaitkevicius, VAINUTIS K. VAITKEVICIUS, Vainutis K Vaitkevicius, Vainutis K. Vaitkevicius, Vainutis Vaitkevicius

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Wayne State University Harper University Hospital The Barbara Ann Karmanos Cancer Institute Sinai Grace Hospital Detroit Medical Center

About

Vainutis K. Vaitkevicius is an author at Wayne State University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	28	1.6K
2	Health Sciences	8	8	647
3	Cell Biology	6	6	177
4	Allergy	1	1	41
5	Endocrinology	1	1	67

Vainutis K. Vaitkevicius

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus Arnold Herskovic, Karen Martz, Muhyi Al‐Sarraf, New England Journal of Medicine	1992	2.1K
Malignant melanoma and central nervous system metastases.Incidence, diagnosis, treatment and survival Magid H. Amer, Muhyi Al‐Sarraf, Laurence H. Baker, Cancer Surgical OncologyTumor InnervationPathologyMalignant MelanomaDermatology	1978	412
Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy Lawrence Leichman, Norman D. Nigro, Vainutis K. Vaitkevicius, The American Journal of Medicine Surgical OncologyPreoperative AdjuvantGastrointestinal OncologyModality TherapyMedicine	1985	217
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer Edgar Ben‐Josef, Anthony F. Shields, Ulka N. Vaishampayan, International Journal of Radiation OncologyBiologyPhysics Pancreatic CancerRadiation TherapyMedicineIntensity-modulated RadiotherapyOncology	2004	185
The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: Ten-year results of 124 patients in a prospective protocol Melvin L. Reed, Vainutis K. Vaitkevicius, Muhyi Al‐Sarraf, Cancer	1981	144
Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU.A southwest oncology group study Laurence H. Baker, Robert W. Talley, Richard C. Matter, Cancer	1976	111
Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer Magid H. Amer, Muhyi Al‐Sarraf, Vainutis K. Vaitkevicius Cancer Advanced HeadNeck CancerNeoadjuvant TherapyMedicineCancer Management	1979	107
HER-2/neu Expression in Pancreatic Adenocarcinoma Michael C. Dugan, Sanaa T. Dergham, Roger Kucway, Pancreas	1997	84
Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma Sanaa T. Dergham, Michael C. Dugan, Roger Kucway, International Journal of Pancreatology	1997	83
Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Ravi Shridhar, Viji Shridhar, Xiaohong Wang, PubMed GeneticsPathologyMolecular GeneticsGenomicsTumor Biology	1996	69

Page 1